India Alternative Protein Fund
-
DATABASE (487)
-
ARTICLES (339)
Founded by Finnish serial entrepreneur and angel investor Riku Asikainen, Helsinki-based Evli Growth Partners invest across market segments, with typical initial stakes of €3m–5m at Series A and B funding stages. The VC is currently building up a total fund of €200m to focus on investments in later-stage growth companies Europe. The first fund, EGP Fund I Ky, was launched in December 2018 and closed at €60m in November 2019. New funds will be set up every two years until 2028.EGP currently has seven companies in its portfolio. In 2021, Evli was co-lead investor for the $54m Series B round of Austrian refurbished electronics goods marketplace Refurbed in August, and investor lead in the €22m Series C round of Polish customized furniture design platform Tylko in March.
Founded by Finnish serial entrepreneur and angel investor Riku Asikainen, Helsinki-based Evli Growth Partners invest across market segments, with typical initial stakes of €3m–5m at Series A and B funding stages. The VC is currently building up a total fund of €200m to focus on investments in later-stage growth companies Europe. The first fund, EGP Fund I Ky, was launched in December 2018 and closed at €60m in November 2019. New funds will be set up every two years until 2028.EGP currently has seven companies in its portfolio. In 2021, Evli was co-lead investor for the $54m Series B round of Austrian refurbished electronics goods marketplace Refurbed in August, and investor lead in the €22m Series C round of Polish customized furniture design platform Tylko in March.
Founded in 2017, Starlight Ventures is a venture capital firm based in Miami, Florida. Investing mainly in US-based startups, the VC currently has 29 startups in its portfolio including enterprises involved in alternative energy, carbon reduction or replacement and alt-proteins sectors. In 2020, the firm joined investment rounds for US deep-tech aerospace startup InterCosmos in July and the $84m Series A for fusion energy tech Commonwealth Fusion in May.
Founded in 2017, Starlight Ventures is a venture capital firm based in Miami, Florida. Investing mainly in US-based startups, the VC currently has 29 startups in its portfolio including enterprises involved in alternative energy, carbon reduction or replacement and alt-proteins sectors. In 2020, the firm joined investment rounds for US deep-tech aerospace startup InterCosmos in July and the $84m Series A for fusion energy tech Commonwealth Fusion in May.
Chairman of the Board, co-founder, co-inventor of NovoNutrients
Russell J. Howard has been co-founder and chairman of the board at NovoNutrients, a San Francisco biotech manufacturer of alt-protein produced using fermentation and CO2, and the research company Oakbio, since the latter’s foundation in 2009. During this period, for a year, Howard also worked as head of commercial strategy at Genome.One, a genetics startup. Howard is also on the board of executives of two Australian pharma companies, Immutep and NeuClone. Previously, between 1997 and 2009, he was CEO at California-based Maxygen, dedicated to the commercialization of molecular breeding and gene shuffling in protein. The year before that, Howard was president and scientific director at global pharma giant GSK in Santa Clara, and between 1994 and 1996, he held the same position at AFFYMAX Research Institute, working on new drugs research. Howard also held long-term research positions, heading up the laboratory at Palo Alto’s DNAX Research Institute of Molecular & Cellular Biology for six years, and earlier spent nine years at Bethesda’s National Institute of Allergy and Infectious Diseases (NIAID) working on identifying new malarial pathogens. The doctor of biochemistry from the University of Melbourne has over 140 peer-reviewed publications. Following his studies, Howard spent three years undertaking postdoctoral research at Australia’s WEHI (formerly the Walter and Eliza Hall Institute of Medical Research).
Russell J. Howard has been co-founder and chairman of the board at NovoNutrients, a San Francisco biotech manufacturer of alt-protein produced using fermentation and CO2, and the research company Oakbio, since the latter’s foundation in 2009. During this period, for a year, Howard also worked as head of commercial strategy at Genome.One, a genetics startup. Howard is also on the board of executives of two Australian pharma companies, Immutep and NeuClone. Previously, between 1997 and 2009, he was CEO at California-based Maxygen, dedicated to the commercialization of molecular breeding and gene shuffling in protein. The year before that, Howard was president and scientific director at global pharma giant GSK in Santa Clara, and between 1994 and 1996, he held the same position at AFFYMAX Research Institute, working on new drugs research. Howard also held long-term research positions, heading up the laboratory at Palo Alto’s DNAX Research Institute of Molecular & Cellular Biology for six years, and earlier spent nine years at Bethesda’s National Institute of Allergy and Infectious Diseases (NIAID) working on identifying new malarial pathogens. The doctor of biochemistry from the University of Melbourne has over 140 peer-reviewed publications. Following his studies, Howard spent three years undertaking postdoctoral research at Australia’s WEHI (formerly the Walter and Eliza Hall Institute of Medical Research).
Beyond Leather Materials / Leap
Vegan leather made from apple waste is recyclable and biodegradable; produces 85% less CO2, uses 99% less water than leather; for sustainable textiles and fashion.
Vegan leather made from apple waste is recyclable and biodegradable; produces 85% less CO2, uses 99% less water than leather; for sustainable textiles and fashion.
Norfund is the sovereign investment fund of Norway, established by the parliament in 1997 and owned by the Ministry of Foreign Affairs. The company has committed NOK 28.4bn in investments into 170 projects in developing countries as of 2020. Norfund has regional offices in Thailand, Costa Rica, Kenya, Mozambique and Ghana to support its activities in Asia, Africa and Latin America. In Asia, its core investment targets are Indonesia, Cambodia, Laos, Vietnam, Myanmar, Bangladesh and Sri Lanka. Norfund primarily invests in three key areas: clean energy, agriculture and fintech. The fund has invested in solar power projects and various food companies in India and various African countries. In Asia, Norfund has invested in Amartha, an Indonesian P2P lending fintech company providing loans to women-led microbusinesses. Norfund also invests in other venture funds, such as Southeast Asia-focused Openspace Ventures Fund III, to expand and diversify their portfolio.
Norfund is the sovereign investment fund of Norway, established by the parliament in 1997 and owned by the Ministry of Foreign Affairs. The company has committed NOK 28.4bn in investments into 170 projects in developing countries as of 2020. Norfund has regional offices in Thailand, Costa Rica, Kenya, Mozambique and Ghana to support its activities in Asia, Africa and Latin America. In Asia, its core investment targets are Indonesia, Cambodia, Laos, Vietnam, Myanmar, Bangladesh and Sri Lanka. Norfund primarily invests in three key areas: clean energy, agriculture and fintech. The fund has invested in solar power projects and various food companies in India and various African countries. In Asia, Norfund has invested in Amartha, an Indonesian P2P lending fintech company providing loans to women-led microbusinesses. Norfund also invests in other venture funds, such as Southeast Asia-focused Openspace Ventures Fund III, to expand and diversify their portfolio.
Founded in 2015 in Guatemala City, the Invariantes Fund invests in technology startups based in the US and Latin America, across different market segments. It is the only VC based in Guatamala, and bills itself as the country’s first early-stage VC firm. As of June 2021, its portfolio includes 24 startups. Invariantes’ most recent investments include participation in the $21m Series A round of US edtech player Reforge, as well in the $130m Series B round of US-based Axiom Space, which is building the first international commercial space station. Both investments were in February 2021.
Founded in 2015 in Guatemala City, the Invariantes Fund invests in technology startups based in the US and Latin America, across different market segments. It is the only VC based in Guatamala, and bills itself as the country’s first early-stage VC firm. As of June 2021, its portfolio includes 24 startups. Invariantes’ most recent investments include participation in the $21m Series A round of US edtech player Reforge, as well in the $130m Series B round of US-based Axiom Space, which is building the first international commercial space station. Both investments were in February 2021.
Russia-China Investment Fund (RCIF) is a private equity fund that invests in projects created to advance economic cooperation between Russia and China. RCIF was founded in 2012 by two government-backed funds: Russian Direct Investment Fund (RDIF) and China Investment Corporation (CIC). RCIF has received US$1 billion commitments from both RDIF and CIC. International institutional investors are expected to commit an additional US$2 billion. RCIF will invest at least 70% of its capital in Russia and CIS countries and around 30% in China.
Russia-China Investment Fund (RCIF) is a private equity fund that invests in projects created to advance economic cooperation between Russia and China. RCIF was founded in 2012 by two government-backed funds: Russian Direct Investment Fund (RDIF) and China Investment Corporation (CIC). RCIF has received US$1 billion commitments from both RDIF and CIC. International institutional investors are expected to commit an additional US$2 billion. RCIF will invest at least 70% of its capital in Russia and CIS countries and around 30% in China.
CEO and founder of Mycorena
Ramkumar Nair graduated in biotechnology at the Cochin University of Science and Technology in Kerala before going to Sweden for postgrad studies in 2013.During his PhD in industrial biotechnology at the University of Borås, he embarked on a research project to create fungi-based proteins from discarded sidestreams generated by food producers. After extensive research in 2017, he founded Mycorena in Gothenburg to produce mycoproteins using fermentation technology.The startup’s first commercial product, Promyc, is now being sold to global food companies as a more sustainable and nutritional alt-protein compared to traditional plant-based proteins.
Ramkumar Nair graduated in biotechnology at the Cochin University of Science and Technology in Kerala before going to Sweden for postgrad studies in 2013.During his PhD in industrial biotechnology at the University of Borås, he embarked on a research project to create fungi-based proteins from discarded sidestreams generated by food producers. After extensive research in 2017, he founded Mycorena in Gothenburg to produce mycoproteins using fermentation technology.The startup’s first commercial product, Promyc, is now being sold to global food companies as a more sustainable and nutritional alt-protein compared to traditional plant-based proteins.
Co-Founder of Lemonilo
Michigan University graduate Ronald Wijaya has a bachelor’s and a master’s in Industrial Engineering. Upon graduation, Wijaya worked at Indonesian confectionery and beverage company PT. United Family Food, first as an Operations Manager and then as a Project Manager. He was also a volunteer on a missionary trip to Kolkata, India, to help underprivileged children and youths. Wijaya continues to work in Lemonilo, the health food company that was born from Konsula’s pivot, and is currently co-CEO of the company.
Michigan University graduate Ronald Wijaya has a bachelor’s and a master’s in Industrial Engineering. Upon graduation, Wijaya worked at Indonesian confectionery and beverage company PT. United Family Food, first as an Operations Manager and then as a Project Manager. He was also a volunteer on a missionary trip to Kolkata, India, to help underprivileged children and youths. Wijaya continues to work in Lemonilo, the health food company that was born from Konsula’s pivot, and is currently co-CEO of the company.
Cloud Angel Fund was co-founded by China Broadband Capital, Sequoia China, Northern Light Venture Capital, GSR Ventures and Wu Capital in 2013. It operates as a VC firm and invests mainly in early-stage startups in China.
Cloud Angel Fund was co-founded by China Broadband Capital, Sequoia China, Northern Light Venture Capital, GSR Ventures and Wu Capital in 2013. It operates as a VC firm and invests mainly in early-stage startups in China.
CGN Industrial Investment Fund
CGN Industrial Investment Fund Co., Ltd. was co-founded by China General Nuclear Power Group (CGN), China Cinda Asset Management Co., Ltd. and China Three Gorges Corporation in Shenzhen in 2008. With over RMB 15 billion assets under management, the fund invests mainly in the sectors of nuclear power, solar power, forestry and mining.
CGN Industrial Investment Fund Co., Ltd. was co-founded by China General Nuclear Power Group (CGN), China Cinda Asset Management Co., Ltd. and China Three Gorges Corporation in Shenzhen in 2008. With over RMB 15 billion assets under management, the fund invests mainly in the sectors of nuclear power, solar power, forestry and mining.
Guangzhou Emerging Industry Development Fund
Guangzhou Emerging Industry Development Fund (Emerging Fund) is a wholly-owned subsidiary of Guangzhou Industrial Investment Fund Management Co Ltd (SFund).It was found in line with the Guangzhou Municipal Government’s industrial upgrade strategy, with the aim of pooling capital, projects and talents together in Guangzhou. The Emerging Fund currently manages a set of government-guided funds and direct investment funds. It also invests in several state-level guidance funds on behalf of the municipal government. It mainly invests in emerging sectors in manufacturing, information technology, service sectors, seed and related industries.
Guangzhou Emerging Industry Development Fund (Emerging Fund) is a wholly-owned subsidiary of Guangzhou Industrial Investment Fund Management Co Ltd (SFund).It was found in line with the Guangzhou Municipal Government’s industrial upgrade strategy, with the aim of pooling capital, projects and talents together in Guangzhou. The Emerging Fund currently manages a set of government-guided funds and direct investment funds. It also invests in several state-level guidance funds on behalf of the municipal government. It mainly invests in emerging sectors in manufacturing, information technology, service sectors, seed and related industries.
Innovative Sports Investment (ISIN) focuses on the eSports sector, backing startups that develop disruptive technologies for athletes and investors through seed investment rounds. Led by Javier Morales, Ander Iñarrairaegui and Javier Colás, the firm also has international offices in Japan, South Korea, India, the US and Argentina.
Innovative Sports Investment (ISIN) focuses on the eSports sector, backing startups that develop disruptive technologies for athletes and investors through seed investment rounds. Led by Javier Morales, Ander Iñarrairaegui and Javier Colás, the firm also has international offices in Japan, South Korea, India, the US and Argentina.
Co-founder, CEO and CFO of Growpal
Ahmad Rizqy Akbar is the CEO and CFO of Growpal, an investment crowdfunding platform for aquaculture and fishery projects. A graduate of Aquaculture studies from Indonesia’s Universitas Brawijaya, he has run his own fish and shrimp farm and had worked at Pertamina Dana Ventura, a venture capital fund owned by national oil and gas firm Pertamina. In 2017, he joined fellow Brawijaya graduate Paundra Noorbaskoro to establish Growpal.
Ahmad Rizqy Akbar is the CEO and CFO of Growpal, an investment crowdfunding platform for aquaculture and fishery projects. A graduate of Aquaculture studies from Indonesia’s Universitas Brawijaya, he has run his own fish and shrimp farm and had worked at Pertamina Dana Ventura, a venture capital fund owned by national oil and gas firm Pertamina. In 2017, he joined fellow Brawijaya graduate Paundra Noorbaskoro to establish Growpal.
Big Idea Ventures Founder Andrew D Ive: Asia will lead cell-based meat innovation
In a wide-ranging interview, the managing general partner of the US- and Singapore-based foodtech investor also expounds on his goal to extend sustainability to the rest of the food sector, combining good returns with doing good
String Bio: Asia's first startup to harness methane gas for protein production
Using bacteria to turn the harmful greenhouse gas into a purer form of protein, String Bio is raising Series B funding to scale production
Future Food Asia 2021: Potential of pulses in the alt-protein space
Asia presents a unique opportunity for pulses as people in the region, who traditionally fractionated pulses for starch, now see protein as a useful byproduct
Mycorena: Fungi-based vegan protein challenging traditional plant-based ingredients
Award-winning Swedish biotech startup is scaling production of mycoprotein to become a key player in the emerging market for functional proteins
New Food Invest: Growing an alternative protein business in Asia
With more than 4bn people, Asia presents unique opportunities and challenges to alternative protein startups. Four leading entrepreneurs shared their experiences at the recent New Food Invest conference
Good Startup: Alt-protein products can be better than real meat
The investor of Eat Just, Ripple Foods and more expects its portfolio companies will exit in the next four to six years, mostly through acquisition
New Food Invest: Plant-based cheese, the next investment boom?
With alt-protein startups experiencing a global funding boom, industry experts and investors share their views about emerging trends in diverse food sectors
Sophie's Bionutrients: Alternative protein from microalgae
Inspired by fish in the ocean, the startup developed microalgae-based flour that can take on unlimited forms, textures or colors to make almost any alt protein product
Dao Foods: Grooming and betting on China's rising alternative protein startups
How can businesses involve Chinese consumers in the environmental cause, even if it isn’t a priority for them? For that, the impact investor-incubator Dao Foods has got its philosophy-led strategy figured out
SWITCH Singapore: Sustainability startups see growing demand from corporates
Sophie’s BioNutrients, Ubiik and Intello Labs also note new trends in technology and supply chain arising from the Covid-19 pandemic, across the food, manufacturing and e-commerce sectors
Singapore, the place to start and grow a cellular agriculture startup
A country that imports over 90% of its food supply, Singapore has turned to foodtech, including cellular agriculture, to safeguard food security, supported by proactive regulators
Plant-based eggs (Part II): The foodtech startups to watch
Here’s a shortlist of the foodtech startups to watch in the global vegan egg market
NovoNutrients: Tackling the dual problems of CO2 emissions and over-fishing
The first to transform CO2 to fish food, NovoNutrients is trialing with industry giants Skretting and Chevron, and will soon raise Series A funding
Xampla: Making strong, low-cost biodegradable plastic from peas
Inspired by the strength of spider silk, the Cambridge University spinoff has produced a plant-based, completely compostable alternative to microplastics
Future Food Asia 2021 announces finalists for $100,000 prize
Ten startups from agrifood tech and cleantech sectors will pitch during the five-day conference, are also eligible for two more prizes from sponsors Cargill and Thai Wah
Sorry, we couldn’t find any matches for“India Alternative Protein Fund”.
POPULAR DATABASE
